“Pharmaceutical companies · bio shares are expected to be successful in clinical trials of vaccines and corona treatments next year” -Yuanta Securities

[ad_1] [한국금융신문 홍승빈 기자] The impact of the new coronavirus infection (Corona 19) on the pharmaceutical and biological industry is expected to continue next year. On the 11th, a Yuanta Securities researcher, Mi-Hwa Seo, said that if a drug that demonstrates efficacy in clinical trials and is approved by the …

Read More »